Following former President Joseph R. Biden Jr.’s prostate cancer diagnosis, the Physicians Committee for Responsible Medicine, a nonprofit with 17,000 doctor members, is sharing resources for people looking for information on nutrition’s role in reducing the risk of prostate cancer and its progression when diagnosed.

New research has found that GLP-1 drugs can substantially reduce the risk of obesity-related cancers — and they’re more effective than getting weight loss surgery.

A class of older drugs used to treat type 2 diabetes may also help slow the progression of prostate cancer, a small study suggests.